Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FLT3-ITD mutation + IDH1 mutation
i
Other names:
FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Receptor Tyrosine Kinase Type III, Fetal Liver Kinase 2, HEL-216, HEL-S-26, Epididymis Luminal Protein 216, Isocitrate Dehydrogenase 1 (NADP+), Epididymis Secretory Protein Li 26, IDH1, Isocitrate Dehydrogenase (NADP(+)) 1, Isocitrate Dehydrogenase 1 (NADP+), Soluble
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2322
;
3417
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3-ITD mutation + IDH1 mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation + IDH1 mutation
Acute Myelogenous Leukemia
FLT3 inhibitor
Sensitive: C3 – Early Trials
FLT3 inhibitor
Sensitive
:
C3
FLT3 inhibitor
Sensitive: C3 – Early Trials
FLT3 inhibitor
Sensitive
:
C3
FLT3-ITD mutation + IDH1 mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation + IDH1 mutation
Acute Myelogenous Leukemia
IDH1 inhibitor
Sensitive: C3 – Early Trials
IDH1 inhibitor
Sensitive
:
C3
IDH1 inhibitor
Sensitive: C3 – Early Trials
IDH1 inhibitor
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.